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Abstract
Introduction: Recently, researchers in a number of studies have explored the association between the Toll-like
receptor 2 (TLR2) Arg753Gln polymorphism and sepsis risk. However, the results were conflicting. In this
meta-analysis, we aimed to confirm the effect of the TLR2 Arg753Gln polymorphism on sepsis risk.
Methods: Relevant records up to 1 June 2015 were retrieved from the PubMed, Embase, and Web of Knowledge
databases. The odds ratios with their corresponding 95 % confidence intervals were used to assess the association
between the TLR2 Arg753Gln polymorphism and sepsis risk. The selection of a fixed or random effects model was
made according to a heterogeneity test in total and subgroup analyses. Sensitivity analysis and publication bias test
were performed to ensure the reliability of our results.
Results: A total of 12 studies with aggregate totals of 898 cases and 1517 controls met our inclusion criteria for
meta-analysis. There were significant associations between the TLR2 Arg753Gln polymorphism and sepsis risk in
overall analyses under two genetic models (the allele comparison and the dominant model). In addition, subgroup
analyses based on age group, ethnicity, sepsis type, and source of control also showed a significant effect of the
TLR2 Arg753Gln polymorphism on sepsis risk.
Conclusions: Our present meta-analysis supports a direct effect of the TLR2 Arg753Gln polymorphism on sepsis
risk, especially in Europeans. The TLR2 Arg753Gln polymorphism might be used as a relevant risk estimate for the
development of sepsis. Studies with larger sample sizes and homogeneous groups of patients with sepsis are
required for further analysis.
Introduction
Sepsis is a complex clinical syndrome that results from a
systemic inflammatory response to bacteria and/or bac-
terial products [1]. It remains a leading cause of death in
the non-cardiac intensive care unit (ICU) despite improve-
ments in antibiotic therapy and supportive care [2, 3].
Therefore, early identification of patients with a high risk
of sepsis after ICU admission is urgently needed to help
determine therapeutic interventions. The host innate im-
mune system plays a key role in the development of sepsis
[4]. Recently, a number of studies have been conducted to
assess the effect of factors in innate immune system on
the susceptibility and outcome of sepsis [5–7]. Among
these factors, Toll-like receptors (TLRs) have been studied
extensively.
TLRs, which are a group of pattern recognition recep-
tors, are composed of ten transmembrane proteins in
humans [8] and are expressed mainly on immune cells,
such as macrophages and dendritic, B, T, and some non-
immune cells [9]. Their important roles have been con-
firmed in regulating inflammatory reactions and activating
adaptive immune response to eliminate infectious patho-
gens [10]. TLR2, a key member of TLR family, could
recognize a variety of bacterial lipoproteins. Several stud-
ies have considered TLR2 as the initial barrier against
infection [11, 12]. The mechanism of TLR2-recognizing
lipoproteins has been elucidated. After TLR2 recognizes
* Correspondence: hellojjx@126.com
1State Key Laboratory of Trauma, Burns and Combined Injury, Institute of
Surgery Research, Daping Hospital, Third Military Medical University,
Chongqing, China
Full list of author information is available at the end of the article
© 2015 Gao et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Gao et al. Critical Care  (2015) 19:416 
DOI 10.1186/s13054-015-1130-3
lipoproteins, it activates MyD88 adaptor–like protein and
triggers a signaling pathway, which induces further im-
mune response [13, 14]. In addition, the TLR2 signaling
pathway is essential to systemic inflammation, which has
been demonstrated in mice with Staphylococcus aureus
sepsis [15]. This evidence suggests that TLR2 may be an
appealing candidate gene for determining sepsis risk.
The TLR2 gene, mapped to chromosome 4q32, con-
sists of three exons. Population-based case–control stud-
ies have shown that the polymorphisms of TLR2 could
influence poor outcomes in a number of diseases, such as
cancer, tuberculosis, and infective endocarditis [16–19].
Among these polymorphisms, the TLR2 Arg753Gln
polymorphism (R753Q, rs5743708), a missense single-
nucleotide polymorphism, has been the most widely dis-
cussed. A previous study suggested that TLR2 Arg753Gln
could lead to diminished activation of intracellular signal-
ing pathways [20]. Recently, a large number of studies
have been conducted to explore the association between
the TLR2 Arg753Gln polymorphism and sepsis risk. How-
ever, the results were inconsistent. Thus, we performed a
meta-analysis to further investigate the effect of the TLR2
Arg753Gln polymorphism on sepsis risk.
Material and methods
Identification and eligibility of relevant studies
We searched all published articles in the PubMed,
Embase, and Web of Knowledge databases up to 1 June
2015. The keywords used were as follows: “Toll-like re-
ceptor 2” or “TLR2”; “sepsis” “septic shock,” or “severe
sepsis”; and “polymorphism,” “variation,” “mutation,” or
“genotype.” Relevant studies were retrieved, and their
references were checked to assess other relevant publica-
tions. Authors were contacted to obtain related data not
revealed in the original articles.
The inclusion criteria were as follows: (1) the study
had to include an evaluation of the association between
the TLR2 Arg753Gln polymorphism and sepsis risk; (2)
the study design had to be a case–control or cohort
study; and (3) the number of the study population geno-
types had to be stated in the article or obtained by con-
tacting the authors. The exclusion criteria were as follows:
(1) study with insufficient number of population genotype;
(2) review, comment, or abstract; and (3) no mutation in
the study population. When an article reported results on
subjects of different ethnicities, we treated each ethnicity
as a separate study.
Data extraction
Two investigators independently screened titles, abstracts,
and full text of the articles to reduce errors and ensure the
reliability of the results. A standardized extraction form
was used for information collection. Disagreement
was resolved by discussion. Information collected from
the selected studies include the first author’s name, publi-
cation year, country in which the study was done, subjects’
ethnicities, subjects’ age groups, sepsis types, source of
control subjects, and genotype numbers in cases and con-
trol subjects for each TLR2 Arg753Gln genotype. Hardy-
Weinberg equilibrium (HWE) was tested based on the
collected data.
Statistical analysis
We performed our meta-analysis under the allele com-
parison model (A vs. B) and the dominant model (AB/
AA vs. BB) for the unknown inherited model of sepsis.
Because of the lack of a mutant homozygote for the
TLR2 Arg753Gln polymorphism, we could not conduct
the related analysis under other inherited models. Odds
ratios (ORs) with their 95 % confidence intervals (CIs)
were used to assess the association between the TLR2
Arg753Gln polymorphism and sepsis risk. The Z-test
was selected to evaluate the statistical significance of
pooled ORs. In addition to total comparisons, stratified
analyses based on age group, ethnicity, sepsis type, and
source of control subjects were also carried out. Hetero-
geneity across studies was evaluated with the I2 value
and a χ2-based Q test. P > 0.10 for the Q test and I2
values less than 50 % revealed no obvious heterogeneity
across studies, allowing us to use a fixed effects model
(the Mantel-Haenszel method); otherwise, a random ef-
fects model (the DerSimonian and Laird method) was
selected. Galbraith plots were used to investigate the
source of between-study heterogeneity. Sensitivity ana-
lysis was performed by sequentially removing individual
studies to assess the reliability of our results. Publication
bias was examined by Begg’s funnel plot qualitatively
(the more symmetrical, the lower the risk of publication
bias) and Egger’s test quantitatively. All statistical analyses
were performed using RevMan 5.2 software (Nordic
Cochrane Center, Copenhagen, Denmark) and STATA
12.0 software (StataCorp, College Station, TX, USA).
Results
Characteristics of eligible studies
A total of 247 records were identified by using different
combinations of search terms in PubMed, Embase, and
Web of Knowledge, and 1 record was identified by
checking reference lists. After excluding 70 duplications,
149 records were removed for their unmatched titles or
abstracts. Full-text reading helped us to remove 18 re-
cords (1 record with insufficient genotype data, 11 re-
views, 2 records without mutation genotype, and 4
meeting abstracts). The author of record with insufficient
genotype data was contacted. However, no answer was re-
ceived. Ultimately, 12 studies (11 records) [21–31] were
included in our meta-analysis according to the inclusion
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and exclusion criteria we had set. The study selection
process is shown in Fig. 1.
Of the 12 included studies, 9 were conducted with
Europeans, 1 in an Asian Han population, 1 in an African
population, and 1 in a mixed ethnicities population. Seven
studies were about sepsis, one was on severe sepsis, and
one was about septic shock. In addition, the study popula-
tions in our included studies consisted of adults (nine
studies) and children (three studies). Five studies used crit-
ically ill patients and another five used healthy populations
as control subjects. All of the studies were consistent with
HWE, except for the study conducted by Lee et al. [25].
The characteristics of selected studies are presented in
Table 1.
Quantitative data synthesis
A total of 12 studies (11 records) with 898 cases and
1517 controls were examined to determine the associ-
ation between the TLR2 Arg753Gln polymorphism and
sepsis risk [21–31]. The combined results of the overall
comparison indicated that there were significant associa-
tions between the TLR2 Arg753Gln polymorphism and
sepsis risk under the allele comparison model and the
dominant model, respectively (for A vs. G, OR 1.76,
95 % CI 1.05–2.95, P = 0.03; for AA/GA vs. GG, OR
1.92, 95 % CI 1.11–3.32, P = 0.02) (Table 2, Figs. 2 and 3).
After removing the study that was not consistent with
HWE [25], the results remained similar (data not shown).
In addition, subgroup analyses showed significant associa-
tions between the TLR2 Arg753Gln polymorphism and
sepsis risk in the adult group. Also, the TLR2 Arg753Gln
polymorphism increased sepsis risk in the European and
critically ill patient subgroups, respectively. The results of
our meta-analysis are presented in Table 2.
Heterogeneity analysis
Statistically significant between-study heterogeneity was
found in overall comparisons in the allele comparison
model (P = 0.01) and the dominant model (P = 0.01), re-
spectively. Subgroup analyses were performed to ensure
the homogeneity of study populations. However, the
between-study heterogeneity did not decrease substan-
tially, except in adult and critically ill patient subgroup
analyses. A Galbraith plot was selected to explore the
source of heterogeneity for total analyses. The studies
conducted by Lee et al. [25] and Tellería-Orriols et al.
Fig. 1 Flow diagram of study identification. Because the study conducted by McDaniel et al. [29] reported results on populations of different ethnicities,
we treated the populations as two separate studies (study 1 and study 2). A total of 12 studies (11 articles) were ultimately included in our meta-analysis.
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[22] were the outliers in the Galbraith plot using the al-
lele comparison model (Additional file 1). After re-
moving those studies, the between-study heterogeneity
decreased substantially and there was no obvious hete-
rogeneity among the remaining studies (P = 0.21, I2 =
25 %). The association between the TLR2 Arg753Gln
polymorphism and sepsis risk changed little (for A vs. G,
OR 1.74, 95 % CI 1.15–2.63, P = 0.009) (Additional file 2).
In addition, the study performed by Tellería-Orriols et al.
[22] was outside the bounds in Galbraith plot in the
dominant model (Additional file 3). After excluding
that study, the between-study heterogeneity decreased
notably and no significant between-study heterogen-
eity was found among the remaining studies (P = 0.14,
I2 = 32 %). There was a significant association between
the TLR2 Arg753Gln polymorphism and sepsis risk
(for AA/GA vs. GG, OR 1.44, 95 % CI 1.02–2.03, P = 0.04)
(Additional file 4). The data derived from the heterogen-
eity analysis are shown in Table 2.
Sensitivity analysis
Sensitivity analysis was performed to evaluate the influ-
ence of each individual study on pooled ORs by remov-
ing each study sequentially. No obvious changes were
found in the results, which confirmed the reliability of
our results in two genetic models.
Publication bias
Publication bias within each study might not represent
all studies. Therefore, Egger’s test and Begg’s funnel plot
were used to evaluate publication bias quantitatively and
qualitatively, respectively. Although slightly asymmet-
rical funnel plots were found in our results (Fig. 4),
Egger’s test did not exhibit obvious publication bias in
the allele comparison model (P = 0.599) and the domin-
ant model quantitatively (P = 0.590).
Discussion
Sepsis is a complex clinical syndrome that results from a
systemic inflammatory response to bacteria and/or bac-
terial products. Previous studies have shown that the
innate immune system is an essential part of sepsis de-
velopment and progression [4, 32, 33]. TLRs and their
associated downstream regulators of immune cell func-
tions play a crucial role in the innate system as the first
line of defense against pathogens. Among all mammalian
TLRs, TLR2 is capable of detecting the widest repertoire
of pathogen-associated molecular patterns. Differences
Table 1 Characteristics of the studies included in the meta-analysis











Cases Controls GG GA AA GG GA AA
Schnetzke et al.,
2015 [21]
Germany European Adult Sepsis Patients with acute
myeloid leukemia
74 81 66 7 1 79 2 0 Yes
Tellería-Orriols et al.,
2014 [22]
Spain European Pediatric Sepsis Healthy 153 66 61 72 20 49 15 2 Yes
Nachtigall et al.,
2014 [23]
Germany European Adult Mix Critically ill patients 98 47 88 10 0 47 0 0 Yes
Bronkhorst, et al.,
2013 [24]
The Netherlands European Adult Sepsis Critically ill patients 79 140 74 5 0 130 10 0 Yes
Lee et al.,
2011 [25]
United States European Adult Mix Patients after
liver transplant
187 405 169 15 3 366 27 12 No
Ahmad-Nejad
et al., 2011 [26]







Healthy 38 57 36 2 0 57 0 0 Yes
Davis et al.,
2010 [31]
United States European Adult Sepsis Healthy 24 53 19 5 0 48 5 0 Yes
Yuan et al.,
2008 [28]
Australia Mix Pediatric Sepsis Healthy 85 409 82 3 0 382 27 0 Yes
McDaniel et al.,
2007 [29] (study 2)
United States European Adult Sepsis Critically ill patients 15 21 12 3 0 17 4 0 Yes
McDaniel et al.,
2007 [29] (study 1)
United States African Adult Sepsis Critically ill patients 16 16 6 10 0 12 4 0 Yes
Lorenz et al.,
2000 [30]
France European Adult Septic
shock
Healthy 91 110 89 2 0 107 3 0 Yes
HWE Hardy-Weinberg equilibrium
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Table 2 Summary of meta-analysis results
0 Tests of association Tests of heterogeneity
Groups Studies, n OR (95 % CI) P value Model Z χ2 P value I2 (%)
All studies
A vs. G 12 1.76 (1.05–2.95) 0.03 RE 2.15 24.60 0.01 55
AA/GA vs. GG 12 1.92 (1.11–3.32) 0.02 RE 2.33 24.11 0.01 54
Subgroup analyses
Adult
A vs. G 9 1.42 (1.00–1.99) 0.05 FE 1.99 11.68 0.17 32
AA/GA vs. GG 9 1.57 (1.09–2.28) 0.02 FE 2.39 10.97 0.20 27
Pediatric
A vs. G 3 1.94 (0.42–8.89) 0.39 RE 0.86 8.29 0.02 76
AA/GA vs. GG 3 2.18 (0.39–12.08) 0.37 RE 0.89 9.75 0.008 79
European
A vs. G 9 1.81 (1.02–3.23) 0.04 RE 2.02 19.18 0.01 58
AA/GA vs. GG 9 1.95 (1.08–3.51) 0.03 RE 2.22 17.43 0.03 54
Sepsis
A vs. G 7 1.86 (0.99–3.52) 0.05 RE 1.93 13.06 0.04 54
AA/GA vs. GG 7 2.01 (0.97–4.19) 0.06 RE 1.87 15.15 0.02 60
Critically ill patients
A vs. G 5 1.95 (1.08–3.51) 0.03 FE 2.22 4.63 0.33 14
AA/GA vs. GG 5 2.09 (1.13–3.86) 0.02 FE 2.34 5.64 0.23 29
Healthy
A vs. G 5 1.76 (0.71–4.35) 0.22 RE 1.22 9.78 0.04 59
AA/GA vs. GG 5 1.88 (0.67–5.25) 0.23 RE 1.20 11.42 0.02 65
HWE
A vs. G 11 2.00 (1.20–3.34) 0.008 RE 2.66 16.12 0.10 38
AA/GA vs. GG 11 2.15 (1.20–3.84) 0.01 RE 2.59 18.23 0.05 45
RE random effects model, FE fixed effects model, HWE Hardy-Weinberg equilibrium
Fig. 2 Forest plot of sepsis risk associated with the Toll-like receptor 2 Arg753Gln polymorphism in the allele comparison model. “Total” in this
figure means the number of alleles in the corresponding group. CI confidence interval, M-H Mantel-Haenszel
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in polymorphism-associated TLR2 may influence the
recognition of pathogens, which could cause the differ-
ent degrees of the host response [34]. Further, the TLR2
Arg753Gln polymorphism was associated with an in-
creased risk of developing tuberculosis [35]. Therefore, we
hypothesized that the TLR2 Arg753Gln polymorphism
could affect the development of sepsis.
To the best of our knowledge, this is the first meta-
analysis in which the relationship between TLR2 poly-
morphism and sepsis risk has been explored. We found
significant associations between the TLR2 Arg753Gln
polymorphism and sepsis risk in two genetic models (the
allele comparison model and the dominant model). In
addition, subgroup analyses based on age group, ethnicity,
sepsis type, and source of control subjects were per-
formed. We noted that the TLR2 Arg753Gln polymorph-
ism was also significantly associated with sepsis risk in
adult, European, sepsis, and critically ill patient subgroups.
These results further proved the important role of the
TLR2 Arg753Gln polymorphism in the development
of sepsis. Since there were fewer than three studies
performed in other subgroups, analyses of other sub-
groups were not conducted; more studies are required
to analyze these conditions.
Our meta-analysis included a study with patients taking
immune-suppressive medications after liver transplant,
and the results also were not inconsistent with HWE.
After we removed that study from the overall analysis, the
results changed little. These patients may not have influ-
enced our results, and more patients taking immune-
suppressive medications are needed to explore this associ-
ation. Some researchers stated that they believe that
pediatric patients may be more sensitive than adult
patients to sepsis risk factors. However, there was no
significant association between the TLR2 Arg753Gln
polymorphism and susceptibility to sepsis in our pediatric
subgroup analysis. This finding may be due to a relatively
small sample size in our meta-analysis. In addition, we
found that only one study was performed in an Asian
population in our meta-analysis. More studies in Asian
populations are needed to estimate the effect of the TLR2
Arg753Gln polymorphism on sepsis risk.
Fig. 3 Forest plot of sepsis risk associated with the Toll-like receptor 2 Arg753Gln polymorphism in the dominant model. “Total” in this figure means
the number of people in the corresponding group. CI confidence interval, M-H Mantel-Haenszel
Fig. 4 Funnel plots of the Toll-like receptor 2 Arg753Gln polymorphism and the risk of sepsis to assess publication bias in different models. a The
allele comparison model. b The dominant model. OR odds ratio
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To better ensure the reliability of our results, we also
explored the source of between-study heterogeneity in
our meta-analysis. Obvious between-study heterogen-
eity was found in both total and subgroup analyses.
Galbraith plots indicated that the studies conducted
by Lee et al. [25] and Tellería-Orriols et al. [22] may
have been the main source of between-study heterogen-
eity. The potential bias of these studies might result from
the populations studied, the studies’ research methods, or
some unknown reasons. After removing these two studies
from the overall analysis, the between-study heterogeneity
decreased substantially and the association between the
TLR2 Arg753Gln polymorphism and sepsis risk was still
significant. Moreover, we conducted sensitivity analyses in
our meta-analysis. Publication bias could have suppressed
false-negative results or could have magnified false-
positive results. In our results, the shape of Begg’s funnel
plots was slightly asymmetrical, but Egger’s test revealed
no obvious publication bias for sepsis risk. All these re-
sults made our conclusions stronger.
How might the TLR2 Arg753Gln polymorphism affect
susceptibility to sepsis? This non-synonymous arginine-
to-glutamine substitution occurs in the intracellular
Toll/interleukin 1 receptor domain of the TLR2 gene. A
gene function study indicated that the TLR2 Arg753Gln
polymorphism could impair tyrosine phosphorylation,
dimerization with TLR6, and MyD88 recruitment with
an effect on nuclear factor κB activation [20, 30]. These
actions result in defective intracellular signaling and im-
paired cytokine secretion in response to peptidoglycan,
lipopeptides, and other known ligands, which may con-
tribute to the development of sepsis. In addition, animal
models have revealed that the defective TLR2 signaling
is a causative factor for increased susceptibility to bacter-
ial disease. All of these findings are in agreement with
our results, indicating that the TLR2 Arg753Gln poly-
morphism may affect the risk of sepsis.
Some limitations of our meta-analysis should be
pointed out. First, the number of included studies and
the sample sizes were moderate, and the heterogeneity
was still existed in some subgroups in our meta-analysis,
which may have contributed to the modest results. Some
studies without sufficient information were excluded,
and some subgroup analyses were not conducted in the
small number of studies. Second, sepsis is a complex
syndrome concerning different pathogens, different eth-
nicities, different age groups, and different underlying
diseases. We could take only some of them into consid-
eration because of their limited information. Third, the
study population in our meta-analysis was focused on
people of European ethnicity. Our conclusions may be
not generalizable to Asian populations. Fourth, many
genes are associated with sepsis. However, we could
not address gene–gene interactions in this meta-analysis,
owing to the lack of related information. Fifth, selection
bias may exist because negative studies are difficult to
publish. Sixth, the quality of our included studies was not
assessed for their limited information. Seventh, we could
discuss only the association between the TLR2 Arg753Gln
polymorphism and sepsis risk in two genetic models for
the lack of a mutant homozygote.
Conclusions
In our meta-analysis, we pooled all available data related
to potential links between the TLR2 Arg753Gln poly-
morphism and sepsis risk. The evidence suggested that
the TLR2 Arg753Gln polymorphism could increase sep-
sis risk, especially in European populations, which may
help us identify high-risk patients. Future large, well-
designed epidemiological studies are required to validate
this conclusion.
Key messages
 Previous studies showed conflicting results regarding
the effect of the TLR2 Arg753Gln polymorphism on
sepsis risk.
 To the best of our knowledge, this is the first
meta-analysis in which the relationship between
TLR2 polymorphism and sepsis risk was explored.
 In our meta-analysis, we found that the TLR2
Arg753Gln polymorphism could increase sepsis
risk, especially in European populations, based on
previous studies.
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Arg753Gln under the dominant model after deleting the study
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